University Of Pittsburgh Physicians

University of Pittsburgh Physicians (UPP), a non-profit subsidiary of the University of Pittsburgh Medical Center, is a healthcare services provider delivering specialized physician services to the federal government, primarily as a prime contractor on delivery orders under indefinite delivery vehicles with the Department of Veterans Affairs. UPP competes on full-and-open (non-set-aside) federal procurements and holds no SBA designations.

UPP's federal footprint is heavily concentrated in veteran healthcare. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 (VISN 4) accounts for 144 awards representing $213 million in combined potential value—87% of UPP's total federal portfolio. VISN 4 procures surgical and clinical physician services from UPP across multiple specialties through single-award indefinite delivery contracts, each running through 2031 or 2032. These include a $25.4 million IDC for affiliate urology services (September 2032), an $11.9 million IDC for cardiac surgery physician services (December 2031), a $22.5 million IDC for vascular physician surgery services (April 2031), a $4.1 million IDC for gynecology physician services (October 2032), and a $1.1 million IDC for affiliate plastic surgery physician services (May 2032). Under these vehicles, UPP issues annual delivery orders at fixed-price-with-economic-price-adjustment rates. Representative recent task orders include a $1.2 million cardiac surgery delivery order (January 2026 through December 2026), a $1.6 million urology delivery order (October 2025 through October 2026), and a $989 thousand vascular surgery delivery order (January 2026 through December 2026). All VISN 4 work is performed on-site at VA facilities in western Pennsylvania, primarily Pittsburgh and surrounding communities. Beyond the VA, UPP holds minor federal exposure: a $251 thousand firm-fixed-price purchase order from the National Institutes of Health National Institute of Child Health and Human Development for ovarian tissue cryopreservation services (December 2022 through December 2027, with four optional one-year extensions), a $2,350 Department of Justice expert-witness services award (2023), and micro-purchases from the Bureau of Prisons and U.S. Attorney's Offices. UPP was also awarded a $1.97 million federal grant as prime recipient from the Bureau of Health Professionals for an addiction medicine fellowship (July 2025 through June 2030) and serves as a sub-recipient on a University of Delaware-led grant involving pediatric voice and swallowing therapy research (award date October 2022).

Activity has declined modestly over the past five years, from 14 awards in 2022 to 3 awards in 2026 (year-to-date through April). However, this decline reflects the shift from multiple small task orders to large consolidated IDCs; the dollar value remains stable, with $213 million tied to the VISN 4 relationship. Eight awards with combined potential value of $4.8 million are scheduled to complete within the next twenty-four months and face recompete. Service Contract Inventory data, covering federal service contracts above $150,000, shows SCI-reportable invoiced revenue of $9 million across FY2022–FY2024 ($3.3 million in FY2022, $2.7 million in FY2023, $2.9 million in FY2024) with a declining FTE trajectory from 5.2 FTEs in FY2022 to 3.7 FTEs in FY2024. Government-paid hourly rates on SCI-reportable prime contracts run a median of $346.97 per hour, with rates ranging from $229.99 per hour at the 10th percentile to $496.18 per hour at the 90th percentile. UPP performs substantially all work directly with no material subcontractor engagement (0% average sub-hours share across prime contracts).

UPP operates as a child entity of University of Pittsburgh Medical Center, leveraging UPMC's clinical infrastructure, facilities, and physician networks to deliver federal healthcare services. The vendor's competitive position rests on its affiliation with an academic medical center and its established track record as VISN 4's primary external surgical services provider, with 308 total awards spanning back to 1999 and $245.6 million in combined potential value across 11 customer agencies, though VISN 4 dominates the portfolio to the point of concentration risk.